Intermittent Fasting and Ovarian Reserve in Women: What the Research Shows on AMH and Reproductive Hormone Safety

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

A team at the University of Illinois Chicago set out to answer a question that had received surprisingly little direct research attention: does intermittent fasting change the reproductive hormone levels of women and men in clinically meaningful ways? With IF growing rapidly in popularity among reproductive-age women, understanding its safety profile for ovarian function, the menstrual cycle, and fertility markers became an urgent evidence gap to close. The review also sought to understand whether women with PCOS — who often use fasting to manage insulin resistance — respond differently from women without hormonal conditions.

Who Was Studied

Participant profile: Reproductive-age adults (18–45 years), mixed BMI ranges from normal weight to obese, all clinical trials conducted in community settings. The women's studies ranged from small pilots (n=10–20) to moderate-sized controlled trials (n=40–80).

How IF protocols worked in these studies: The most commonly used protocol was 16:8 time-restricted eating, where participants consumed all food within an 8-hour window (typically 10am–6pm or noon–8pm) and fasted for the remaining 16 hours. A smaller number of studies used 5:2 fasting (500–600 kcal on two non-consecutive days) or alternate-day fasting.

What the Researchers Found

Reproductive Hormones in Healthy Women

Across studies in women without known hormonal conditions, the most consistent finding was reassuring: moderate intermittent fasting did not significantly alter core reproductive hormones.

The most clinically relevant finding for women considering fasting: 16:8 time-restricted eating, when practised by healthy women, does not appear to disrupt the hormonal signals that govern ovulation and the menstrual cycle.

Reproductive Hormones in Women With PCOS

The picture for women with PCOS was more active — and in many cases, favourable:

• Free testosterone reduced significantly in several PCOS studies, with reductions of approximately 25–40% reported across individual trials
• Fasting insulin and HOMA-IR (insulin resistance index) improved markedly, consistent with the broader evidence base on IF and metabolic health
• LH:FSH ratio — a key PCOS diagnostic marker — normalised in some trials following sustained IF
• Menstrual cycle regularity improved in several PCOS cohorts, with women reporting return of regular cycles after weeks of structured fasting
• Androstenedione reduced in some studies alongside free testosterone improvements

AMH and Ovarian Reserve: What the Data Shows

Anti-Müllerian hormone (AMH) — the primary blood marker of ovarian reserve — was directly measured in only a small subset of included studies. The available data showed:

• No significant decline in AMH was observed in healthy women practising 16:8 TRE for up to 16 weeks
• In PCOS women, AMH at baseline is typically elevated above normal ranges; weight loss achieved through IF was associated with modest normalisation of AMH toward expected reference ranges in some studies
• The reviewers concluded that direct IF-specific AMH data remains sparse and that larger, longer trials specifically measuring AMH as a primary outcome are needed

What Did Not Change

• Lean mass and muscle mass: largely preserved across fasting protocols when protein intake was adequate
• Bone density markers: no significant changes observed in the trials that measured them
• Thyroid hormone levels (TSH, T4): not significantly altered in the trials that included thyroid measurements

What the Researchers Concluded

The authors concluded that moderate intermittent fasting — particularly 16:8 time-restricted eating — appears to be safe for reproductive hormone profiles in most women of reproductive age. For women with PCOS, who often have elevated androgens and disrupted insulin signalling, IF may offer additional reproductive benefits beyond weight management. The reviewers noted that direct evidence for IF effects on AMH and ovarian reserve specifically remains limited, and called for future randomised trials measuring these endpoints directly.

What This Means If You Fast

• If you are a healthy woman without hormonal conditions: The available evidence suggests that 16:8 intermittent fasting does not disrupt LH, FSH, estrogen, or testosterone. Your menstrual cycle should not be significantly affected if you are eating adequately during your eating window.
• If you have PCOS: IF may be particularly beneficial — improvements in testosterone, insulin resistance, and cycle regularity have been observed across multiple studies. Work with a healthcare provider to monitor your response over time.
• If you are trying to conceive: Direct AMH data is reassuring but limited. Avoid very aggressive fasting protocols (OMAD daily, extended 24-hour fasts) and ensure adequate caloric and protein intake in your eating window. Consult a reproductive specialist before using fasting as a fertility strategy.
• Cycle phase matters: Research suggests different fasting lengths work better at different cycle phases. The pre-menstrual phase (days 20–28) is the most sensitive for hormonal disruption — shorter fasting windows during this phase may help preserve progesterone.
• Watch for warning signals: If your periods become irregular, shorter, or stop entirely after starting fasting, shorten your fasting window immediately. This is a reliable early signal that your fasting load exceeds what your hormonal environment can support.

Study Limitations

• Most individual trials included in the review had small sample sizes (fewer than 50 participants)
• Follow-up durations were generally short (under 12 weeks), limiting conclusions about long-term reproductive health effects
• AMH was rarely measured as a primary or secondary endpoint across the included trials — this is the most significant gap in the evidence base
• Most studies did not control for or standardise the menstrual cycle phase at which blood draws occurred, introducing noise into hormonal comparisons
• Heterogeneity of IF protocols (16:8, 5:2, ADF) and eating window timing makes cross-study comparisons difficult
• Most trials were conducted in Western populations and may not generalise across all ethnicities and health contexts
• Self-reported dietary adherence in several studies may not accurately reflect actual fasting behaviour

Source

Cienfuegos S, Cordo S, Gabel K, Kalam F, Ezpeleta M, Wiley S, Tamatam S, Bhutani S, Desai OM, Varady KA. (2022). Effect of Intermittent Fasting on Reproductive Hormone Levels in Females and Males: A Review of Human Trials. Nutrients, 14(11), 2343. PMID: 35684143

Frequently Asked Questions

Does intermittent fasting lower AMH levels?

Based on current evidence, moderate intermittent fasting (16:8 TRE) does not appear to significantly lower AMH in healthy women. AMH was rarely measured directly in IF trials, so the dataset is limited, but no study reviewed has shown a meaningful AMH decline from moderate fasting protocols.

Is 16:8 fasting safe for women who want to get pregnant?

The available evidence suggests 16:8 TRE does not disrupt reproductive hormones in healthy women. However, if you are actively trying to conceive, consult a reproductive specialist before using fasting. Very aggressive protocols (OMAD, 20:4 daily) are not well-studied in women trying to conceive and are best approached with medical guidance.

Can intermittent fasting help PCOS-related fertility problems?

Research suggests yes — multiple studies show that IF reduces free testosterone, improves insulin resistance (a core PCOS driver), and can restore menstrual cycle regularity in women with PCOS. These are meaningful improvements for fertility. However, this should be pursued under medical supervision, not as a standalone treatment.

How long does it take for fasting to affect reproductive hormones?

The studies reviewed observed hormonal changes (particularly in PCOS) after 8 to 24 weeks of consistent fasting. Short-term fasting (under 4 weeks) showed minimal hormonal changes in either direction, suggesting the body adapts gradually rather than responding immediately.

What is the difference between fasting's effect on healthy women versus women with PCOS?

In healthy women, the primary finding is hormonal stability — IF does not significantly change their reproductive hormones. In women with PCOS, who begin with elevated androgens and insulin resistance, IF often produces beneficial changes: reduced testosterone, improved insulin sensitivity, and more regular cycles. The same dietary pattern has different starting points and therefore different outcomes in these two groups.

Related Research and Articles

• Intermittent fasting and female fertility: what the research shows
• Intermittent fasting and PCOS: what the research shows
• How intermittent fasting affects women's hormones
• Fasting and estrogen: what women need to know
• Intermittent fasting and thyroid health in women
• How to sync intermittent fasting to your menstrual cycle
• Intermittent fasting and progesterone in women

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.